{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:55:08Z","timestamp":1792652108382,"version":"4.5.0"},"reference-count":119,"publisher":"Royal Society of Chemistry (RSC)","issue":"4","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":["RSC Adv."],"abstract":"<jats:p>In an attempt to collect clinical data about HDAC inhibitors as very significant anticancer drugs, we aimed to compare data and reveal the impact of the structural features to help \u2013 develop better cancer therapy.<\/jats:p>","DOI":"10.1039\/d5ra09034b","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T13:04:59Z","timestamp":1768482299000},"page":"3430-3442","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["HDAC inhibitors as anticancer drugs: chemical diversity, clinical trials, challenges and perspectives"],"prefix":"10.1039","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2597-7419","authenticated-orcid":false,"given":"Abdallah E.","family":"Abdallah","sequence":"first","affiliation":[{"name":"Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, 11884, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"292","published-online":{"date-parts":[[2026]]},"reference":[{"key":"D5RA09034B\/cit1\/1","doi-asserted-by":"crossref","first-page":"104695","DOI":"10.1016\/j.bioorg.2021.104695","volume":"109","author":"Abdallah","year":"2021","journal-title":"Bioorg. Chem."},{"key":"D5RA09034B\/cit2\/1","doi-asserted-by":"crossref","first-page":"137041","DOI":"10.1016\/j.molstruc.2023.137041","volume":"1298","author":"Al Ward","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"1","key":"D5RA09034B\/cit3\/1","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/14756366.2021.2017911","volume":"37","author":"Abdallah","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"D5RA09034B\/cit4\/1","first-page":"587","author":"Abdallah","year":"2023","journal-title":"Drug Des., Dev. Ther."},{"issue":"23","key":"D5RA09034B\/cit5\/1","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1080\/17568919.2024.2419361","volume":"16","author":"Saleh Al Ward","year":"2024","journal-title":"Future Med. Chem."},{"issue":"3","key":"D5RA09034B\/cit6\/1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1042\/bj20021321","volume":"370","author":"Ruijter","year":"2003","journal-title":"Biochem. J."},{"issue":"13","key":"D5RA09034B\/cit7\/1","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00018-012-0921-9","volume":"69","author":"Reichert","year":"2012","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"D5RA09034B\/cit8\/1","doi-asserted-by":"crossref","first-page":"371832","DOI":"10.1155\/2011\/371832","volume":"2011","author":"Peserico","year":"2011","journal-title":"BioMed Res. Int."},{"issue":"1","key":"D5RA09034B\/cit9\/1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coph.2007.12.002","volume":"8","author":"Abel","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"issue":"3","key":"D5RA09034B\/cit10\/1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1139\/o05-041","volume":"83","author":"Verdone","year":"2005","journal-title":"Biochem. Cell Biol."},{"issue":"10","key":"D5RA09034B\/cit11\/1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1158\/1541-7786.MCR-07-0324","volume":"5","author":"Dokmanovic","year":"2007","journal-title":"Mol. Cancer Res."},{"issue":"1","key":"D5RA09034B\/cit12\/1","doi-asserted-by":"crossref","first-page":"129383","DOI":"10.1155\/2011\/129383","volume":"2011","author":"Hayakawa","year":"2011","journal-title":"BioMed Res. Int."},{"issue":"32","key":"D5RA09034B\/cit13\/1","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1200\/JCO.2009.22.1291","volume":"27","author":"Lane","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"D5RA09034B\/cit14\/1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-024-01551-8","volume":"17","author":"Shi","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"D5RA09034B\/cit15\/1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1111\/febs.13061","volume":"282","author":"Parra","year":"2015","journal-title":"FEBS J."},{"key":"D5RA09034B\/cit16\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s10020-018-0027-4","volume":"24","author":"Ke","year":"2018","journal-title":"Mol. Med."},{"key":"D5RA09034B\/cit17\/1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sbi.2019.01.004","volume":"59","author":"Porter","year":"2019","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"6","key":"D5RA09034B\/cit18\/1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cytogfr.2012.08.002","volume":"23","author":"Icardi","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"issue":"11","key":"D5RA09034B\/cit19\/1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.tips.2015.08.001","volume":"36","author":"Gomes","year":"2015","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"D5RA09034B\/cit20\/1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbagrm.2017.12.002","volume":"1861","author":"Yanginlar","year":"2018","journal-title":"Biochim. Biophys. Acta, Gene Regul. Mech."},{"key":"D5RA09034B\/cit21\/1","doi-asserted-by":"crossref","first-page":"110607","DOI":"10.1016\/j.biopha.2020.110607","volume":"131","author":"Liu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"D5RA09034B\/cit22\/1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2018.06.025","volume":"33","author":"Sun","year":"2018","journal-title":"EBioMedicine"},{"issue":"15_suppl","key":"D5RA09034B\/cit23\/1","doi-asserted-by":"crossref","first-page":"8507","DOI":"10.1200\/jco.2008.26.15_suppl.8507","volume":"26","author":"Bociek","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"D5RA09034B\/cit24\/1","first-page":"47","author":"Ververis","year":"2013","journal-title":"Biol.: Targets Ther."},{"issue":"3","key":"D5RA09034B\/cit25\/1","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.3390\/molecules20033898","volume":"20","author":"Mottamal","year":"2015","journal-title":"Molecules"},{"issue":"37","key":"D5RA09034B\/cit26\/1","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.1038\/sj.onc.1210620","volume":"26","author":"Xu","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"D5RA09034B\/cit27\/1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pharmthera.2014.04.004","volume":"143","author":"Bose","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"D5RA09034B\/cit28\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-6-68","volume":"6","author":"Kuljaca","year":"2007","journal-title":"Mol. Cancer"},{"issue":"3","key":"D5RA09034B\/cit29\/1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ijc.1602","volume":"97","author":"Kwon","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"7","key":"D5RA09034B\/cit30\/1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.7150\/jca.34091","volume":"11","author":"Liao","year":"2020","journal-title":"J. Cancer"},{"issue":"1","key":"D5RA09034B\/cit31\/1","first-page":"109","volume":"21","author":"Takai","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"D5RA09034B\/cit32\/1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/B978-0-12-394387-3.00005-7","volume":"116","author":"Matthews","year":"2012","journal-title":"Adv. Cancer Res."},{"issue":"3","key":"D5RA09034B\/cit33\/1","first-page":"324","volume":"20","author":"Sanaei","year":"2021","journal-title":"Iran. J. Pharm. Res."},{"key":"D5RA09034B\/cit34\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-7-90","volume":"7","author":"\u00d6zda\u011f","year":"2006","journal-title":"BMC Genomics"},{"issue":"4","key":"D5RA09034B\/cit35\/1","first-page":"777","volume":"26","author":"Sudo","year":"2011","journal-title":"Oncol. Rep."},{"issue":"1","key":"D5RA09034B\/cit36\/1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/epi.3.1.5736","volume":"3","author":"Mariadason","year":"2008","journal-title":"Epigenetics"},{"issue":"12","key":"D5RA09034B\/cit37\/1","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1515\/hsz-2017-0155","volume":"398","author":"Tang","year":"2017","journal-title":"Biol. Chem."},{"issue":"3","key":"D5RA09034B\/cit38\/1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.11403","volume":"107","author":"Kawai","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"10","key":"D5RA09034B\/cit39\/1","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"7","key":"D5RA09034B\/cit40\/1","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"10","key":"D5RA09034B\/cit41\/1","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3390\/cancers12102903","volume":"12","author":"Lobo","year":"2020","journal-title":"Cancers"},{"key":"D5RA09034B\/cit42\/1","doi-asserted-by":"crossref","first-page":"122615","DOI":"10.1016\/j.lfs.2024.122615","author":"Preziosi","year":"2024","journal-title":"Life Sci."},{"issue":"15_suppl","key":"D5RA09034B\/cit43\/1","doi-asserted-by":"crossref","first-page":"16058","DOI":"10.1200\/jco.2008.26.15_suppl.16058","volume":"26","author":"Cheung","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"D5RA09034B\/cit44\/1","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1038\/sj.bjc.6605293","volume":"101","author":"Munster","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"1","key":"D5RA09034B\/cit45\/1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10637-010-9503-6","volume":"30","author":"Schneider","year":"2012","journal-title":"Invest. New Drugs"},{"issue":"4","key":"D5RA09034B\/cit46\/1","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s10637-018-0696-4","volume":"37","author":"Teknos","year":"2019","journal-title":"Invest. New Drugs"},{"issue":"18","key":"D5RA09034B\/cit47\/1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2011.38.1350","volume":"30","author":"Younes","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"D5RA09034B\/cit48\/1","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1158\/1078-0432.CCR-13-2235","volume":"20","author":"Gray","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"D5RA09034B\/cit49\/1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1182\/blood-2016-02-699520","volume":"128","author":"Assouline","year":"2016","journal-title":"Blood"},{"issue":"1","key":"D5RA09034B\/cit50\/1","first-page":"2090271","volume":"2016","author":"Vitfell-Rasmussen","year":"2016","journal-title":"Sarcoma"},{"issue":"5","key":"D5RA09034B\/cit51\/1","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1080\/10428194.2020.1861270","volume":"62","author":"Holkova","year":"2021","journal-title":"Leuk. Lymphoma"},{"issue":"4","key":"D5RA09034B\/cit52\/1","first-page":"648","volume":"6","author":"Jain","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"5","key":"D5RA09034B\/cit53\/1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/bjc.2011.13","volume":"104","author":"Razak","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"11","key":"D5RA09034B\/cit54\/1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/pbc.24694","volume":"60","author":"Zorzi","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"D5RA09034B\/cit55\/1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10637-015-0252-4","volume":"33","author":"Eigl","year":"2015","journal-title":"Invest. New Drugs"},{"issue":"19","key":"D5RA09034B\/cit56\/1","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-13-0735","volume":"19","author":"Brunetto","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"D5RA09034B\/cit57\/1","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/cam4.3813","volume":"10","author":"Ueno","year":"2021","journal-title":"Cancer Med."},{"issue":"15_suppl","key":"D5RA09034B\/cit58\/1","doi-asserted-by":"crossref","first-page":"14514","DOI":"10.1200\/jco.2008.26.15_suppl.14514","volume":"26","author":"Undevia","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"D5RA09034B\/cit59\/1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1078-0432.CCR-15-0624","volume":"22","author":"Evens","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"D5RA09034B\/cit60\/1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3324\/haematol.2016.154377","volume":"102","author":"Ribrag","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"D5RA09034B\/cit61\/1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-025-14370-y","volume":"25","author":"Gui","year":"2025","journal-title":"BMC Cancer"},{"issue":"20","key":"D5RA09034B\/cit62\/1","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1158\/1078-0432.CCR-08-0376","volume":"14","author":"de Bono","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"17","key":"D5RA09034B\/cit63\/1","doi-asserted-by":"crossref","first-page":"13660","DOI":"10.3390\/ijms241713660","volume":"24","author":"Mei","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5\u20136","key":"D5RA09034B\/cit64\/1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2119\/molmed.2011.00020","volume":"17","author":"Furlan","year":"2011","journal-title":"Mol. Med."},{"issue":"8","key":"D5RA09034B\/cit65\/1","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41375-020-0735-y","volume":"34","author":"Rambaldi","year":"2020","journal-title":"Leukemia"},{"key":"D5RA09034B\/cit66\/1","doi-asserted-by":"crossref","first-page":"1095121","DOI":"10.3389\/fneur.2023.1095121","volume":"14","author":"Comi","year":"2023","journal-title":"Front. Neurol."},{"key":"D5RA09034B\/cit67\/1","doi-asserted-by":"crossref","first-page":"100787","DOI":"10.1016\/j.curtheres.2025.100787","volume":"102","author":"Anjum","year":"2025","journal-title":"Curr. Ther. Res."},{"issue":"22","key":"D5RA09034B\/cit68\/1","doi-asserted-by":"crossref","first-page":"e167081","DOI":"10.1172\/jci.insight.167081","volume":"8","author":"Cascio","year":"2023","journal-title":"JCI Insight"},{"issue":"21","key":"D5RA09034B\/cit69\/1","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.V120.21.3676.3676","volume":"120","author":"Child","year":"2012","journal-title":"Blood"},{"issue":"15","key":"D5RA09034B\/cit70\/1","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1158\/1078-0432.CCR-13-0312","volume":"19","author":"Venugopal","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"D5RA09034B\/cit71\/1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/bjd.14427","volume":"175","author":"Child","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"D5RA09034B\/cit72\/1","volume-title":"A Multicenter Phase II Study of the Efficacy and Safety of Quisinostat (An HDAC Inhibitor) in Combination with Paclitaxel and Carboplatin Chemotherapy (CT) in Patients (Pts) with Recurrent Platinum Resistant High Grade Serous Epithelial Ovarian, Primarily Peritoneal or Fallopian Tube Carcinoma Cancer (OC)","author":"Tjulandin","year":"2017","unstructured":"S.Tjulandin ,  et al. ,  A Multicenter Phase II Study of the Efficacy and Safety of Quisinostat (An HDAC Inhibitor) in Combination with Paclitaxel and Carboplatin Chemotherapy (CT) in Patients (Pts) with Recurrent Platinum Resistant High Grade Serous Epithelial Ovarian, Primarily Peritoneal or Fallopian Tube Carcinoma Cancer (OC) ,  American Society of Clinical Oncology ,  2017"},{"issue":"21","key":"D5RA09034B\/cit73\/1","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1182\/blood.V120.21.4061.4061","volume":"120","author":"Raje","year":"2012","journal-title":"Blood"},{"issue":"21","key":"D5RA09034B\/cit74\/1","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1182\/blood.V124.21.4764.4764","volume":"124","author":"Vogl","year":"2014","journal-title":"Blood"},{"issue":"3","key":"D5RA09034B\/cit75\/1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/onco.13673","volume":"26","author":"Amengual","year":"2021","journal-title":"Oncologist"},{"issue":"9","key":"D5RA09034B\/cit76\/1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1634\/theoncologist.2015-0043","volume":"20","author":"Iyer","year":"2015","journal-title":"Oncologist"},{"issue":"14","key":"D5RA09034B\/cit77\/1","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2174\/0929867311320140006","volume":"20","author":"Rajak","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"7","key":"D5RA09034B\/cit78\/1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1586\/era.10.88","volume":"10","author":"Grant","year":"2010","journal-title":"Expert Rev. Anticancer Ther."},{"issue":"9","key":"D5RA09034B\/cit79\/1","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/s41591-024-03076-6","volume":"30","author":"Horwitz","year":"2024","journal-title":"Nat. Med."},{"key":"D5RA09034B\/cit80\/1","doi-asserted-by":"crossref","first-page":"1164514","DOI":"10.3389\/fimmu.2023.1164514","volume":"14","author":"Lian","year":"2023","journal-title":"Front. Immunol."},{"issue":"02","key":"D5RA09034B\/cit81\/1","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1055\/s-0042-1749373","volume":"4","author":"Gu","year":"2022","journal-title":"Pharm. Fronts"},{"key":"D5RA09034B\/cit82\/1","doi-asserted-by":"crossref","first-page":"932914","DOI":"10.3389\/fphar.2022.932914","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Pharmacol"},{"issue":"21","key":"D5RA09034B\/cit83\/1","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1002\/cncr.34974","volume":"129","author":"Parveen","year":"2023","journal-title":"Cancer"},{"issue":"5","key":"D5RA09034B\/cit84\/1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/s00044-024-03210-6","volume":"33","author":"Cai","year":"2024","journal-title":"Med. Chem. Res."},{"issue":"13","key":"D5RA09034B\/cit85\/1","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2217\/fon-2016-0526","volume":"13","author":"Connolly","year":"2017","journal-title":"Future Oncol."},{"issue":"6","key":"D5RA09034B\/cit86\/1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/mc.22983","volume":"58","author":"Lee","year":"2019","journal-title":"Mol. Carcinog."},{"issue":"6","key":"D5RA09034B\/cit87\/1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1517\/13543784.2011.577737","volume":"20","author":"Boumber","year":"2011","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"1","key":"D5RA09034B\/cit88\/1","first-page":"1","volume":"2","author":"Hesham","year":"2018","journal-title":"Arch. Pharm. Sci. Ain Sham Univ."},{"key":"D5RA09034B\/cit89\/1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.2147\/DDDT.S237957","author":"Al-Sanea","year":"2020","journal-title":"Drug Des., Dev. Ther."},{"issue":"1","key":"D5RA09034B\/cit90\/1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.08.016","volume":"277","author":"Witt","year":"2009","journal-title":"Cancer Lett."},{"key":"D5RA09034B\/cit91\/1","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.canlet.2021.09.002","volume":"521","author":"Sun","year":"2021","journal-title":"Cancer Lett."},{"key":"D5RA09034B\/cit92\/1","first-page":"1","author":"Kamiunten","year":"2025","journal-title":"Int. J. Hematol."},{"issue":"8","key":"D5RA09034B\/cit93\/1","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1111\/cas.15431","volume":"113","author":"Utsunomiya","year":"2022","journal-title":"Cancer Sci."},{"key":"D5RA09034B\/cit94\/1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/tbcr-23-31","volume":"4","author":"Zhang","year":"2023","journal-title":"Transl. Cancer Res."},{"key":"D5RA09034B\/cit95\/1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.breast.2022.10.018","volume":"66","author":"Zhou","year":"2022","journal-title":"Breast"},{"key":"D5RA09034B\/cit96\/1","volume-title":"Phase 2 Study of HDAC Inhibitor Tucidinostat in Combination with Anti-PD-1 Antibody in Patients with Locally Advanced or Metastatic Urothelial Carcinoma","author":"Liu","year":"2023","unstructured":"Z.Liu ,  et al. ,  Phase 2 Study of HDAC Inhibitor Tucidinostat in Combination with Anti-PD-1 Antibody in Patients with Locally Advanced or Metastatic Urothelial Carcinoma ,  American Society of Clinical Oncology ,  2023"},{"issue":"1","key":"D5RA09034B\/cit97\/1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-024-01624-8","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"9","key":"D5RA09034B\/cit98\/1","first-page":"1014","volume":"52","author":"Yoshimitsu","year":"2022","journal-title":"Jpn. J. Clin. Oncol."},{"key":"D5RA09034B\/cit99\/1","volume-title":"Tucidinostat Plus Toripalimab in Patients with Unresectable or Metastatic Melanoma: an Open-Label, Single-Arm Phase II Study","author":"Mao","year":"2024","unstructured":"L.Mao ,  et al. ,  Tucidinostat Plus Toripalimab in Patients with Unresectable or Metastatic Melanoma: an Open-Label, Single-Arm Phase II Study ,  American Society of Clinical Oncology ,  2024"},{"key":"D5RA09034B\/cit100\/1","doi-asserted-by":"publisher","DOI":"10.1159\/000545709","author":"Bi","year":"2025","journal-title":"Acta Haematol."},{"issue":"28","key":"D5RA09034B\/cit101\/1","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1200\/JCO.21.00944","volume":"39","author":"Connolly","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"D5RA09034B\/cit102\/1","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41467-024-52528-7","volume":"15","author":"Baretti","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"D5RA09034B\/cit103\/1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43682-025-00037-z","volume":"5","author":"Hallab","year":"2025","journal-title":"Epigenet. Commun."},{"issue":"4","key":"D5RA09034B\/cit104\/1","doi-asserted-by":"crossref","first-page":"e28892","DOI":"10.1002\/pbc.28892","volume":"68","author":"Bukowinski","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"D5RA09034B\/cit105\/1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2009.07881.x","volume":"147","author":"Blum","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"13","key":"D5RA09034B\/cit106\/1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S1470-2045(11)70265-0","volume":"12","author":"Younes","year":"2011","journal-title":"Lancet Oncol."},{"issue":"4","key":"D5RA09034B\/cit107\/1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/cncr.31817","volume":"125","author":"Grivas","year":"2019","journal-title":"Cancer"},{"issue":"3","key":"D5RA09034B\/cit108\/1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cllc.2023.01.013","volume":"24","author":"Johnson","year":"2023","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"D5RA09034B\/cit109\/1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00280-017-3494-3","volume":"81","author":"Chan","year":"2018","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"5","key":"D5RA09034B\/cit110\/1","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/CMR.0000000000000818","volume":"32","author":"Weber","year":"2022","journal-title":"Melanoma Res."},{"key":"D5RA09034B\/cit111\/1","volume-title":"Melanoma","author":"Weber","year":"2020","unstructured":"J. S.Weber ,  et al., Preclinical and clinical studies of a class I\/IV HDAC inhibitor, mocetinostat , in  Melanoma ,  American Society of Clinical Oncology ,  2020"},{"issue":"1","key":"D5RA09034B\/cit112\/1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/bjc.2011.527","volume":"106","author":"Pili","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"1","key":"D5RA09034B\/cit113\/1","doi-asserted-by":"crossref","first-page":"e005871","DOI":"10.1136\/jitc-2022-005871","volume":"11","author":"Marquardt","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"Suppl 1","key":"D5RA09034B\/cit114\/1","doi-asserted-by":"crossref","first-page":"i50","DOI":"10.1093\/neuonc\/noad073.194","volume":"25","author":"Marquardt","year":"2023","journal-title":"Neuro-Oncology"},{"issue":"7","key":"D5RA09034B\/cit115\/1","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1182\/blood-2007-03-078576","volume":"110","author":"Soriano","year":"2007","journal-title":"Blood"},{"issue":"5","key":"D5RA09034B\/cit116\/1","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1182\/blood-2003-12-4333","volume":"104","author":"Kuendgen","year":"2004","journal-title":"Blood"},{"issue":"2","key":"D5RA09034B\/cit117\/1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/leu.2010.276","volume":"25","author":"Quintas-Cardama","year":"2011","journal-title":"Leukemia"},{"issue":"6","key":"D5RA09034B\/cit118\/1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1634\/theoncologist.2011-0031","volume":"16","author":"Mohammed","year":"2011","journal-title":"Oncologist"},{"issue":"1","key":"D5RA09034B\/cit119\/1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1186\/s12885-016-2957-y","volume":"16","author":"Caponigro","year":"2016","journal-title":"BMC Cancer"}],"container-title":["RSC Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2026\/RA\/D5RA09034B","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:43:22Z","timestamp":1783449802000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.rsc.org\/ra\/article\/16\/4\/3430-3442\/909316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":119,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,1,13]]}},"URL":"https:\/\/doi.org\/10.1039\/d5ra09034b","relation":{"has-review":[{"id-type":"doi","id":"10.1039\/D5RA09034B\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1039\/D5RA09034B\/v2\/review2","asserted-by":"object"}]},"ISSN":["2046-2069"],"issn-type":[{"value":"2046-2069","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}